Bioteque Corporation (TPEX:4107)
Taiwan · Delayed Price · Currency is TWD 114.50
+1.00 (0.88%)
May 29, 2026, 1:30 PM CST
Bioteque Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,935 | 8,350 | 8,558 | 7,623 | 7,727 | 7,935 | |
Market Cap Growth | -7.66% | -2.43% | 12.27% | -1.34% | -2.62% | -13.91% |
Enterprise Value | 6,556 | 7,472 | 7,895 | 7,170 | 7,539 | 7,134 |
Last Close Price | 114.50 | 120.50 | 118.27 | 101.72 | 98.95 | 97.65 |
PE Ratio | 11.28 | 15.49 | 16.20 | 16.84 | 15.66 | 18.40 |
Forward PE | - | 23.50 | 23.50 | 20.51 | 15.05 | 15.05 |
PS Ratio | 3.67 | 3.91 | 4.13 | 3.92 | 3.84 | 4.35 |
PB Ratio | 2.35 | 2.32 | 2.49 | 2.39 | 2.55 | 2.83 |
P/TBV Ratio | 2.35 | 2.32 | 2.49 | 2.39 | 2.55 | 2.83 |
P/FCF Ratio | 13.06 | 13.76 | 14.16 | 12.57 | - | - |
P/OCF Ratio | 11.29 | 12.57 | 12.18 | 11.22 | 11.99 | 16.91 |
EV/Sales Ratio | 3.03 | 3.50 | 3.81 | 3.69 | 3.75 | 3.91 |
EV/EBITDA Ratio | 7.65 | 9.05 | 9.97 | 9.94 | 10.79 | 10.77 |
EV/EBIT Ratio | 9.54 | 11.15 | 12.28 | 12.36 | 13.04 | 13.02 |
EV/FCF Ratio | 10.79 | 12.31 | 13.06 | 11.82 | - | - |
Debt / Equity Ratio | 0.12 | 0.17 | 0.22 | 0.28 | 0.29 | 0.17 |
Debt / EBITDA Ratio | 0.49 | 0.71 | 0.92 | 1.22 | 1.23 | 0.70 |
Debt / FCF Ratio | 0.69 | 0.98 | 1.23 | 1.48 | - | - |
Net Debt / Equity Ratio | -0.41 | -0.30 | -0.25 | -0.21 | -0.13 | -0.29 |
Net Debt / EBITDA Ratio | -1.63 | -1.29 | -1.08 | -0.93 | -0.56 | -1.23 |
Net Debt / FCF Ratio | -2.27 | -1.76 | -1.42 | -1.10 | 4.80 | 9.95 |
Asset Turnover | 0.45 | 0.46 | 0.45 | 0.43 | 0.48 | 0.49 |
Inventory Turnover | 3.97 | 3.90 | 3.80 | 3.60 | 3.61 | 3.53 |
Quick Ratio | 2.17 | 3.64 | 3.30 | 2.84 | 2.72 | 2.64 |
Current Ratio | 2.53 | 4.27 | 3.92 | 3.35 | 3.34 | 3.27 |
Return on Equity (ROE) | 16.61% | 15.30% | 15.93% | 14.55% | 16.92% | 15.78% |
Return on Assets (ROA) | 8.97% | 9.00% | 8.68% | 7.97% | 8.67% | 9.22% |
Return on Invested Capital (ROIC) | 24.20% | 20.91% | 19.62% | 17.88% | 19.79% | 24.85% |
Return on Capital Employed (ROCE) | 17.90% | 16.30% | 15.80% | 14.60% | 14.80% | 16.80% |
Earnings Yield | 6.93% | 6.46% | 6.17% | 5.94% | 6.39% | 5.44% |
FCF Yield | 7.66% | 7.27% | 7.06% | 7.96% | -1.06% | -1.03% |
Dividend Yield | 4.80% | 4.56% | 4.23% | 4.42% | 4.55% | 4.61% |
Payout Ratio | 63.04% | 64.26% | 59.03% | 68.91% | 63.19% | 64.28% |
Buyback Yield / Dilution | 22.19% | -0.09% | -0.01% | 0.03% | -0.07% | -0.01% |
Total Shareholder Return | 27.03% | 4.47% | 4.21% | 4.46% | 4.48% | 4.59% |